What Does National CineMedia (NCMI) Do? - Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
National CineMedia (ticker: NCMI) is a cinema advertising company whose core business is US theater screen advertising. Its key features include revenue underpinned by exclusive contracts with major theater chains, a programmatic digital shift, and earnings/stock-price outlook tied to the box-office recovery and ad-market cycle.
National CineMedia is a cinema advertising company that runs an advertising business leveraging theater screens across the United States. It sells exposure space to national, regional, and local advertisers through pre-show on-screen ads and theater lobby media.
Its core business is the operation of a screen-advertising network built on long-term, exclusive partnerships with major US theater chains. Reaching a broad audience in the immersive theater environment is the differentiator versus digital advertising.
💰 How does National CineMedia make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| National Advertising | Core | Key revenue source centered on upfront buys and multi-market campaigns by national advertisers |
| Regional & Local Advertising | Key growth pillar | Sales to regional and local advertisers through a distributed sales network |
Revenue is anchored by screen advertising sold to national advertisers, complemented by regional and local advertising. Recently, the company has been expanding the share of digital transactions by connecting programmatic digital out-of-home (DOOH) inventory with external trading platforms. The revenue stream is tied to box-office performance and the ad market, so exposure and pricing tend to improve together during periods with a strong film slate. The digital shift is lifting ad efficiency and measurability, contributing to revenue diversification.
📐 National CineMedia's market cap and company scale
Market capitalization is $227.7M, with 248 people employees.
National CineMedia is a small-cap company specialized in cinema advertising and ranks on the smaller side within the ad-agency and ad-tech sector. Comparable peers in scale and business model within the advertising sector include programmatic player MGNI, retargeting-focused CRTO, and the diversified ad holding company OMC. Its positioning, focused on the distinctive medium of theaters, is the key differentiator.
📈 National CineMedia outlook and share-price trend
In the near term, the box-office recovery and the strength of the film release lineup are the key variables driving ad impressions and pricing. Mid- to long-term growth drivers are the expansion of programmatic digital out-of-home (DOOH) advertising and the omnichannel integration of digital inventory, which can absorb measurable ad demand and underpin revenue diversification. However, shifts in theater-going trends, competition for leisure time from streaming, and an ad-market slowdown remain potential volatility factors, so earnings can fluctuate along the box-office cycle.
- Expansion of programmatic digital out-of-home (DOOH) and digital advertising
- Improvement in ad impressions and pricing on the back of a box-office recovery
⚔️ National CineMedia's core strengths and risks
Media dominance based on exclusive contracts with theater chains is a strength, while reliance on box-office performance and the ad market is the core risk.
💪 Core Strengths
⚠️ Core Risks
🔄 National CineMedia's competitors and related (beneficiary) stocks
Within its direct competitive space, National CineMedia competes for ad budgets with advertising-sector peers such as programmatic player MGNI, retargeting and performance-focused CRTO, and diversified ad holding company OMC. Related names include its media partners and theater traffic providers, the theater operators AMC and CNK, along with premium-format exhibitor IMAX, which share the box-office flow and are grouped together accordingly.
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Magnite Inc | $23.77 | +0.9% | $3.4B | 21.8 | 3.6 | 19.58% | - | |
| Criteo S.A | $17.44 | +0.4% | $973.7M | 8.8 | 0.8 | 9.42% | - | |
| Omnicom Group Inc | $79.01 | -0.6% | $21.7B | 67.7 | 2.5 | 5.52% | 4.41% |
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| AMC Entertainment Holdings Inc | $2.46 | +4.2% | $2.2B | - | - | - | - | |
| Cinemark Holdings Inc | $35.08 | -0.2% | $4.1B | 19.5 | 8.2 | 45.43% | 0.88% | |
| Imax Corp | $52.09 | +1.4% | $2.9B | 71.3 | 8.0 | 12.1% | - |
✅ Investor checklist for National CineMedia
When evaluating National CineMedia, investors should review the structural characteristics of the theater-advertising medium, the box-office cycle, and the progress of the digital shift in parallel. The fact that revenue is simultaneously exposed to box-office performance and the ad market is the key consideration.
| Checklist | What to verify | Current status |
|---|---|---|
| 🎬 Box-Office Momentum | Film release lineup and theater traffic trends | Box-office cycle in a recovery phase |
| 📊 Digital Shift | Extent of programmatic digital out-of-home (DOOH) transaction expansion | Expansion underway |
| 💵 Profitability Trend | Margin flow driven by ad pricing and cost structure | Needs monitoring |
| ⚔️ Ad Market | Advertiser budget environment and pricing trends | Macro-sensitive |
If box-office weakness and an ad-market slowdown occur at the same time, both revenue and profitability can come under pressure simultaneously. Competition for leisure time from streaming and shifts in theater-going behavior also act as long-term risks, so dependence on the box-office cycle should be examined carefully.
National CineMedia is a small-cap company with cinema-advertising media dominance based on exclusive theater-chain contracts and the potential of its digital shift. However, given its high dependence on the box office and the ad market, a barbell approach combining staged buying with a long-term perspective—while monitoring the cyclical flow—is recommended.